Pharmology's lead executive connecting microbiome-based new material development with business strategy.
She oversees functional material development for improving skin and scalp concerns, productization strategy, and global business direction.
With experience authoring 50 SCI-level papers and developing 60 patents, she leads the development of microbiome-based new materials for improving skin and scalp concerns.
She connects the discovery and purification of beneficial microorganisms, natural materials, and new material research with productization, presenting next-generation bio approaches for restoring balance in the skin ecosystem.
© 2026 PHARMOLOGY All right reserved
